Summary & Overview
CPT 80305: Presumptive Drug Test by Visual Read
CPT code 80305 covers presumptive drug screening tests visually read by a laboratory analyst without instrument assistance. These manual, point-of-care style assays are used to rapidly screen for one or multiple drug classes on a single date and are widely used across clinical laboratories, outpatient clinics, and urgent care settings. The code matters nationally because it represents a common, low-complexity screening service that intersects clinical workflows, laboratory operations, and payer coverage policies.
Key payers in scope include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of what the code denotes, the typical service setting, and how it is categorized for billing. The publication provides benchmarks and payer policy considerations relevant to reimbursement and claims processing for manual presumptive drug tests, plus clinical context on when visually read screenings are used versus instrumented testing.
This summary is designed to help billing managers, laboratory administrators, and policy analysts understand the clinical purpose of CPT code 80305, the payer landscape, and the operational contexts where the code is applied. Data not available in the input will be noted where applicable.
Billing Code Overview
CPT code 80305 describes a presumptive drug test by direct optical observation, performed by a laboratory analyst. The analyst reads test results visually without instrument assistance to screen for one or more drug classes on a single date.
Service Type: Laboratory — Point-of-Care/Manual Presumptive Drug Screening
Typical Site of Service: Clinical laboratory, point-of-care locations such as outpatient clinics, urgent care centers, or other settings where manual drug screening is performed
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 28-year-old employee presenting to an occupational health clinic after a workplace incident requiring a post-accident drug screen. The clinic collects a urine specimen under chain-of-custody procedures and sends a portion to the on-site laboratory. The lab analyst performs a presumptive drug screen using an immunoassay test strip read visually (no instrument). The result is documented as a preliminary positive or negative for multiple drug classes (e.g., amphetamines, opioids, cocaine, cannabinoids). If presumptive positive, the specimen is segregated for confirmatory testing (e.g., GC-MS or LC-MS/MS) and results communicated to the ordering clinician. Typical workflow steps: ordering by clinician, specimen collection and labeling, analyst-performed presumptive assay with direct optical reading, documentation of findings, and referral for confirmatory testing or counseling as clinically indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional Component | Use when billing only the professional interpretation portion of a split-service test if applicable in context of lab-performed reading when payer requires separation. |
59 | Distinct Procedural Service | Use when this presumptive test is separately identifiable from other services performed the same day. |
76 | Repeat Procedure or Service by Same Physician/Other Qualified Health Care Professional | Use when the presumptive test is repeated for the same patient on the same day by the same provider. |
77 | Repeat Procedure by Another Physician/Other Qualified Health Care Professional | (Note: 77 is not listed in provided modifiers; omitted.) |
90 | Reference (Outside) Laboratory | Use when testing is performed by an outside reference laboratory but billed by the ordering entity. |
91 | Repeat Clinical Diagnostic Laboratory Test | Use when the same lab test is repeated on a subsequent specimen to monitor or confirm results. |
52 | Reduced Services | Use when the presumptive testing is partially reduced or not fully performed. |
53 | Discontinued Procedure | Use when testing was started but discontinued due to insufficient specimen or other clinical reasons. |
59 | Distinct Procedural Service | (Already listed above) |
90 | Reference (Outside) Laboratory | (Already listed above) |
91 | Repeat Clinical Diagnostic Laboratory Test | (Already listed above) |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| Data not available in the input. | ||
| Data not available in the input. | ||
| Data not available in the input. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
| Data not available in the input. | ||
| Data not available in the input. | ||
| Data not available in the input. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
80305 | Presumptive drug test(s) by direct optical observation only | Primary procedure: visually read presumptive screen for multiple drug classes performed by lab analyst. |
| Data not available in the input. | ||
| Data not available in the input. |